Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
Business Wire•06/08/2026•16:01 ET
0
Whiz Insights
Verastem Oncology Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates
AVMAPKI® FAKZYNJA® CO-PACK net product revenue of $25.1 million
Get started
Create a free account to read the full story.